ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04658	Th1 and Th2 cell differentiation	7/26	96/7206	3.19501188236e-08
ko04659	Th17 cell differentiation	7/26	106/7206	6.38205155766e-08
ko04650	Natural killer cell mediated cytotoxicity	6/26	97/7206	9.43094088523e-07
ko05340	Primary immunodeficiency	4/26	30/7206	3.42479429199e-06
ko05321	Inflammatory bowel disease (IBD)	4/26	56/7206	4.30698362411e-05
ko04060	Cytokine-cytokine receptor interaction	6/26	191/7206	4.74132251349e-05
ko05162	Measles	5/26	120/7206	5.85636236631e-05
ko05168	Herpes simplex infection	5/26	182/7206	0.000415640751479
ko05167	Kaposi's sarcoma-associated herpesvirus infection	5/26	191/7206	0.000518899779967
ko05145	Toxoplasmosis	4/26	126/7206	0.000988817135239
ko04630	Jak-STAT signaling pathway	4/26	132/7206	0.0011762642871
ko04621	NOD-like receptor signaling pathway	4/26	157/7206	0.00223054576261
ko04217	Necroptosis	4/26	178/7206	0.00351674902422
ko05152	Tuberculosis	4/26	187/7206	0.00419728851829
ko04660	T cell receptor signaling pathway	3/26	124/7206	0.00968670980294
ko04380	Osteoclast differentiation	3/26	134/7206	0.0119586899546
ko05164	Influenza A	3/26	167/7206	0.0214982830005
ko05140	Leishmaniasis	2/26	75/7206	0.0295674436354
ko04612	Antigen processing and presentation	2/26	77/7206	0.0310398660385
ko04664	Fc epsilon RI signaling pathway	2/26	77/7206	0.0310398660385
ko04062	Chemokine signaling pathway	3/26	201/7206	0.0346875251083
ko04662	B cell receptor signaling pathway	2/26	88/7206	0.039641653769
ko04064	NF-kappa B signaling pathway	2/26	96/7206	0.0464031602709